Abstract
For viruses capable of establishing persistent infection such as the herpes simplex viruses (HSV) and human immunodeficiency viruses (HIV), subunit viral vaccines are likely to prove safer than live-attenuated or whole-inactivated viral vaccines. Numerous structural and nonstructural viral proteins have been shown to be immunogenic in both animals and humans. HSV vaccines containing such immunogenic components do not prevent primary infection in animals. However, they prevent the development of clinical disease, reduce latent infection and decrease the likelihood of subsequent herpetic recurrences. Limited evaluation of subunit HIV vaccines has demonstrated their immunogenicity and shown that they prevent experimental infection of chimpanzees. While protection from disease may be adequate for herpetic infections, it is likely that prevention of infection is an important goal for HIV vaccines. Improved understanding of both the protective as well as the detrimental immune responses produced by viral infection should permit rational selection of subunit immunogens. This, together with the development of safer and more potent synthetic adjuvants, should permit the production of new effective subunit viral vaccines. In addition to providing protection for the uninfected host, these vaccines may be useful as immunotherapeutic agents in the treatment of patients with latent/persistent infection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Pearson, G.R. and Scott, R.E. Proc. Natl. Acad. Sci. USA. 74:2546–2550, 1977.
Thornton, B., Baskerville, A., Bailey, N.A., Melling, J.M. and Hambleton, P. Vaccine 2:141–148, 1984.
Roberts, P.L, Duncan, B.E., Raybould T.J.G. and Watson, D.H. J. Gen. Virol. 66:1073–1085, 1985.
Watson, R.J., Weis, J.H., Salstrom,J.S. and Enquist, LW. Science 218:381–384, 1982.
Lasky. L.A., Dowbenko, D., Simonsen, C.C. and Berman, P.W. Biotechnology 2:527–532, 1984.
Pachl, C., Burke, R.L., Struve, L.L., Sanchez-Pescador, L., Van Nest, G., Masiarz, F. and Dina, D. J.Virol. 61:315–325, 1987.
Struve, L.L., Brown-Shimer, S., Pachl, C., Najarian, R. Dina, D. and Burke, R.L J. Virol. 61:326–335, 1987.
Paoletti, E., Perkus, M.E. and Piccini, A. Antiviral Res. 1(suppl. 1):301–307. 1985.
Paoletti, E., Lipinskas, B.R., Samsonoff, C., Mercer S. and Panicali, D. Proc. Natl. Acad. Sci. USA. 81:193–197, 1984.
Cremer, K.J., Mackett, M., Wolhenberg, C., Notkins, A.L. and Moss, B. Science 228:737–740. 1985.
Martin, S., Moss, B., Berman P.W., Laskey, L.A. and Rouse, B.T. J. Virol. 61:726–734, 1987.
Wachsman, M., Aurelian, L., Smith, C.C., Perkus, M.E. and Paoletti, E. J. Infect. Dis. 159:625–634. 1989.
Lane, J.M. and Millar, J.D. Am. J. Epidemiol. 93:238–240, 1971.
Moss, B. In: High Technology Route to Vaccines (Eds. G.R.Dreesman, L.G. Bronson, and R.C.Kennedy), Am. Soc. Microbiol., Washington, D.C., 1985, pp.69–74.
Buller, R.M.L, Chakrabarti, S., Cooper, J.A., Twardzik, D.R. and Moss, B. J. Virol. 62:866–874, 1989.
Beale, J. Nature (London). 302:476–477. 1983.
McDermott, M.R., Graham, F.L., Hanke, T. and Johnson, D.C. Virology 169:244–247, 1989.
Krisna, S., Blacklaws, B.A., Overton, H.A., Bishop, D.H.L. and Nash, A.A. J. Gen. Virol. 70:1805–1914, 1989.
Valenzuela, P., Coit, D., Medina-Selby, M.A., Kuo, C.H., VanNest, G., Burke, R.L., Bull, P., Urdea, M.S. and Graves, P. Biotechnology 3:323–326, 1985.
Pellet, P.P., Kousoulas, K.G., Pereira, L. and Roizman, B. J. Virol. 53:243–253, 1985.
Kikuchi, G.E., Coligan, J.E., Holland, T.C., Levine, M., Glorioso, J.C. and Nairn, R. J. Virol. 52:806–815, 1984.
Marlin, S.D., Holland, T.C., Levine, M. and Glorioso, J.C. J. Virol. 53:128–136, 1985.
Eisenberg, R.J., Long, D., Pereira, L, Hampar, B., Zweig, M. and Cohen, G.H. J. Virol. 41:478–488, 1982.
Cohen, G.H., Dietzschold, B., Ponce de Leon, M., Long, D., Golub, E.A., Varrichio, A., Pereria, L and Eisenberg, R.J. J. Virol. 49:102–108, 1984.
Dietzschold, B., Eisenberg, R.J., Ponce de Leon, M., Golub, E., Hudecz, F., Varricho, A. and Cohen, G.H. J. Virol. 52:431–435, 1984.
Eisenberg, R.J., Long, D., Ponce de Leon, M., Matthews, J.M., Spear, P.G., Gibson, M.G., Lasky, L.A., Berman, P., Golub, E. and Cohen, G.H. J. Virol. 53:634–644, 1985.
Eisenberg, R.J., Cerini, C.P., Heilman, C.J., Joseph, A.D., Dietzschold, B., Golub, E., Long, D., Ponce de Leon, M. and Cohen, G.H. J. Virol. 56:1014–1017, 1985.
Schrier, R. D., Pizer, L.I. and Moorhead, J.W. J. Immunol. 130:1413–1418, 1983.
Chan, W.L. Immunology 49:343–352, 1983.
Long, D., Madara, T.J., Ponce de Leon, M., Cohen, G.H., Montgomery, P.C. and Eisenberg, R.J. Infect. Immun. 43:761–764, 1984.
Cappel, R. Arch. Virol. 52:29–35, 1976.
Cappel, R., de Cuyper, F., and Rickaert, F. Arch. Virol. 65:15–23, 1980.
Koff, W.C., Showalter, S.D., Hampar, B., and Fidler, I.J. Science 228:495–497, 1985.
Renis, H.A., Eidson, E.E., Mathews, J. and Gray, J.E. Infect. Immun. 14:571–578, 1976.
Meignier, B., Jourdier, T.M., Norrild, B., Pereira, L., and Roizman, B. J. Infect. Dis. 155:921–930, 1987.
Stroop, W.G. and Schaefer, D.C. J. Infect. Dis. 153:721–731, 1986.
Richards, J.T., Kern, E.R., Overall Jr., J.C., and Glasgow, L.A. J. Infect. Dis. 144:464–471. 1981.
Rooney, J.F., Wohlenberg, C., Cremer, K.J., and Notkins, A.L. J. Infect. Dis. 159:974–976. 1989.
Dix, R.D. and Mills, J. J. Med. Virol. 17:9–18, 1985.
Balachandran, N., Bacchetti, S., and Rawls, W.E. Infect. Immun. 37:1132–1137, 1982.
Darai, G., Schwaier, A., Komitowski, D., and Munk, K. J. Infect. Dis. 137:221–226, 1978.
Stanberry, L.R., Kern, E.R., Richards J.T., Abbott, T.M., and Overall Jr., J.C. J. Infect. Dis. 146:397–404, 1982.
Stanberry, L.R., Kern, E.R., Richards, J.T., and Overall Jr., J.C. Intervirology 24:226–231, 1985.
Stanberry, L.R. J. Med. Virol. 28:125–128, 1989.
Stanberry, L.R., Kit, S., and Myers, M.G. J. Virol. 55:322–328, 1985.
Harrison, C.J., Jenski, L, Voychehovski, T., and Bernstein, D.I. Antiviral Res. 10:209–224, 1988.
Hill, T.J., Field, H.J., and Blyth, W.A. J. Gen. Virol. 28:341–353, 1975.
Field, H.J. In: Antiviral Agents: The Development and Assessment of Antiviral Chemotherapy Volume I (Ed. H.J.Field), CRC Press, Boca Raton, Florida, 1988, pp. 67–84.
Slichtova, V., Kutinova, L, and Vonka, V. Arch. Virol. 66:207–214, 1980.
Kitces, E.N., Morahan, P.S., Tew, J.G., and Murray, B.K. Infect. Immun. 16:955–960, 1977.
Thomson, T.A., Hilfenhaus, J., Moser, H., and Morahan, P.S. Infect. Immun. 41:556–562, 1983.
Klein, R.J., Buimovici-Klein, E., Moser, H., Moucha, R., and Hilfenhaus, J. Arch. Virol. 68:73–80, 1981.
Baker, M.B., Larson, C.L, Ushijima, R.N., and Anderson, F.D. Infect. Immun. 10:1220–1234, 1974.
Walz, M.A., Price, R.J., Hayashi, K., Katz, B.J. and Notkins, A.L J. Infect. Dis. 135:744–752, 1977.
Zaia, J.A., Palmer, E.L. and Feorino, P.M. J. Infect. Dis. 132:660–666. 1975.
Spruance, S.L. and McKeough, M.B. Antiviral Res. 9:295–313, 1988.
Nesburn, A.B., Cook, M.L., and Stevens, J.G. Arch. Ophthalmol. 88:412–417, 1972.
Green, M.T., Dunkel, E.C., and Courtney, R. Invest. Ophthalmol. Vis. Sci. 25:1436–1449, 1984.
Rector, J.T., Lausch, R.N., and Oakes, J.E. Infect. Immun. 38:168–174, 1982.
Tullo, A.B., Shimfeld, C., Blyth, W.A., Hill, T.J., and Easty, D.L. Arch. Ophthalmol. 101:961–964, 1983.
Atherton, S.A. and Streilein, J.W. Current Eye Res. 6:133–139, 1987.
Ksander, B.R. and Hendricks, R.L. Invest. Ophthalmol. Vis. Sci. 28:1986–1993, 1987.
Wander, A.H., Bubel, H.C., and McDowell, S.G. Arch. Virol. 95:197–209, 1987.
Willey, D.R., Cantin, E.M., Hill, L.R., Moss, B., Notkins, A.L., and Openshaw, H. J. Infect. Dis. 158:1382–1386, 1988.
Hendricks, R.L., Tao, M.S.P., and Glorioso, J.C. J. Immunol. 142:263–269, 1989.
Meignier, B., Longnecker, R., and Roizman. B. J. Infect. Dis. 158:602–614. 1988.
Stanberry, L.R., Bernstein, D.I., Burke, R.L., Pachl, C., and Myers, M.G. J. Infect. Dis. 155:914–920. 1987.
Berman, P.W., Vogt, P.E., Gregory, T., Lasky, L.A., and Kern, E.R. J. Infect. Dis. 157:897–902. 1988.
Stanberry, L.R., Ward, M.A., Burke, R.L, and Myers, M.G. Pediatr. Res. 25:191A, 1989.
Skinner, G.R.B., Williams, D.R., Buchan, A., Whitney, J., Harding, M., and Bodfish, K. Med. Microbiol. Immunol. 166:119–132, 1978.
Hilfenhaus, J., Moser, H., Herrmann, A., and Mauler, R. In: Developments in Biological Standardization, Volume 52: Herpes Virus of Man and Animal: Standardization of Procedures (Eds. M. Bonneau and H. Hennessen), S. Karger, Basel, 1982, pp. 321–331.
Berman, P., Gregory, T., Crase, D., and Lasky, L Science 227:1490–1492, 1985.
Weinberg, A. and Merigan, T.C. J. Immunol. 140:294–298, 1988.
Watari, J., Dietzschold, B., Szokan, G. and Heber-Katz, E. J. Exp. Med. 157:459–470. 1987.
Stanberry, L.R., Myers, M.G., Stephanopoulos, D.E., and Burke, R.L. J. Gen. Virol. 70:3177–3185, 1989.
Stanberry, L.R., Bernstein, D.I., Kit, S., and Myers, M.G. J. Infect. Dis. 153:1055–1061, 1986.
Bernstein, D.I., Stanberry, L.R., Kappes, J.C., Burke, R.L. and Myers, M.G. J. Infect. Dis. 157:1178–1186. 1988.
Committee on Issues and Priorities for New Vaccine Development, In: New Vaccine Development: Establishing Priorities, National Academy Press, Washington, D.C., 1985, pp 280–312.
Sanchez-Pescador, L., Burke, R.L., Ott, G. and Van Nest, G. J. Immunol. 141:1720–1727, 1988.
Jones, W.R., Judd, S.J., Ing, R.M.Y., Powell, J., Bradley, J., Denholm, E.H., Mueller, U.W., Griffin, P.D. and Stevens, V.C. Lancet 1:1295–1298, 1988.
Cappel, R., Sprecher, S., Rickaert, F. and de Cuyper, F. Arch. Virol. 73:61–67, 1982.
Cappel, R., Sprecher, S., de Cuyper, F. and De Braekeleer, J. J. Med. Virol. 16:137–145, 1985.
Skinner, G.R.B., Woodman, C., Hartley, C., Buchan, A., Fuller, A., Wiblin, C., Wilkins, G. and Meiling, J. In: Developments in Biological Standardization, Volume 52: Herpes Virus of Man and Animal: Standardization of Procedures (Eds. M. Bonneau and H. Hennessen), S. Karger, Basel, 1982, pp 333–344.
Hilleman, M. R., Larson, V.N., Lehman, E.D., Salerno, R.A., Conard, P.G. and McLean, A.A. In: The Human Herpesviruses: An Interdisciplinary Perspective (Eds. A. J. Nahmias, W.R. Dowdle and R.F. Schinazi), Elsevier, New York, 1981, pp 503–506.
Mertz, G.J., Peterman, G., Ashley, R., Jourden, J.L., Salter, D., Morrison, L., McLean, A. and Corey, L. J. infect. Dis. 150:242–249, 1984.
Woodman, C.B.J., Buchan, A., Fuller, A., Hartley, C., Skinner, G.R.B., Stocker, D., Sugrue, D., Clay, J.C., Wilkins, G., Wilbin, C. and Meiling, J. Bri. J. Vener. Dis. 59:311–313, 1983.
Skinner, G.R.B., Fink, C.G., Cowan, M., Buchan, A., Fuller, A., Hartley, C.E., Durham, J., Wiblin, C and Meiling, J. Med. Mircobiol. Immunol. 176:161–168, 1987.
Corey, L, Mertz, G., Ashley, R. and Benedetti, J. Abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy, New York City, October, 1987, Abst. #1288.
Ashley, R., Mertz, G.J. and Corey, L J. Virol. 61:264–268, 1987.
Sheridan, J.F. and Aurelian, L. Diagn. Immunol. 1:245–256, 1983.
Donnenberg, A.D., Bell, R.B. and Aurelian, L. Cell. Immunol. 56:526–539, 1980.
Donnenberg, A.D., Chaikof, E. and Aurelian, L. Infect. Immun. 30:99–109, 1980.
Iwasaka, T., Sheridan, J.F. and Aurelian, L. Infect. Immun. 42:955–964, 1983.
Schiff, B.L and Kern, A.B. Postgrad. Med. 15:32–36, 1954.
Kern, A.B. and Schiff, B.L J. Invest. Dermatol. 33:99–109, 1959.
Lazar, M.P. Amer. Med. Assoc. Arch. Dermatol. 71:70–74, 1955.
Goldman, L. Arch. Dermatol. 84:1025–1030, 1961.
Blank, H. and Haines, H.G. J. Invest. Dermatol. 61:223–225, 1973.
Frank, S.B. J. Invest. Dermatol. 1:267–282, 1938.
Wise, T.G., Pavan, P.R. and Ennis, F.A. J. Infect. Dis. 136:706–711, 1977.
Dundarov, P., Andonov, P., Bakalov, B., Nechev, K. and Tomov, C. In: Developments in Biological Standardization, Volume 52: Herpes Virus of Man and Animal: Standardization of Procedures (Eds. M. Bonneau and H. Hennessen), S. Karger, Basel, 1982, pp. 351–358.
Kern, A.B. and Schiff, B.L. Arch. Virol. 89:844–845, 1964.
Scriba, M. Med. Microbiol. Immunol. 171:33–42, 1982.
Slichtova, V., Kutinova, L. and Vonka, V. Arch. Virol. 71:75–78, 1982.
Kutinova, L., Benda, R., Kalos, Z., Dbaly, V., Votruba, T., Kvicalova, E., Petroska, P., Doutlik, S., Kaminkova, J., Domorazkova, E., Bergmonov, V., Krcmar, A., Suchankova, A., Nemeckova, S. and Vonka, V. Vaccines 6:223–228, 1988.
Stanberry, L.R., Burke, R.L. and Myers, M.G. J. Infect. Dis. 157:156–163, 1988.
Ekwo, E.E., Wong, Y.W. and Myers, M.G. Amer. J. Obstet. Gynecol. 134:102–103, 1979.
Adam, E., Dreesman, G.E., Kaufman, R.H. and Melnick, J.L Amer. J. Obstet. Gynecol. 137: 827–830, 1980.
Myers, M.G., Bernstein, D.I., Harrison, C.J. and Stanberry, L.R. Antiviral Res. 10:83–88, 1988.
Stanberry, L.R., Harrison, C.J., Bernstein, D.I., Burke, R.L, Shukla, R., Ott, G. and Myers, M.G. Antiviral Res. 11:203–214, 1989.
Harrison, C.J., Bernstein, D.J., Jenski, L, Stanberry, L.R. and Myers, M.G. Abstracts of the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy, Los Angeles, California, October, 1988, pp 236.
Bernstein, D.I., Loo, L.S. and Kohl, S. Antiviral Res. 10:279–284, 1988.
Ho, R.J.Y., Burke, R.L. and Merigan, T.C. J. Virol. 63:2951–2958, 1989.
Pereira, L. In: The Herpesviruses, Volume 3 (Ed. B. Roizman), Plenum Press, New York, 1985, pp 383–404.
Brunell, P.A., Novelli, V.M., Keller, P.M. and Ellis, R.W. J. Infect. Dis. 156:430–435. 1987.
Jones, F. and Grouse, C. J. Virol. 62:2701–2711, 1988.
Dolyniuk, M., Pritchett, R. and Kieff, E. J. Virol. 17:935–949, 1976.
Qualtiere, L.F., Chase, R. and Pearson, G.R. J. Immunol. 129:814–818. 1982.
Patent Report, Vaccine 5:251, 1987.
Myers, M.G., Duer, H.I. and Hausler, C.K. J. Infect. Dis. 142:414–420, 1980.
Matsunaga, Y., Yamanishi, K. and Takahashi, M. Infect. Immun. 37:407–412, 1982.
Myers, M.G., Stanberry, L.R. and Edmond, B.J. J. Infect. Dis. 151:106–113, 1985.
Walz-Cicconi, M.A., Rose, R.M., Dammin, G.J. and Weller, T.H. Arch. Virol. 88:265–277, 1987.
Provost, P.J., Keller, P.M., Banker, F.S., Keech, B.J., Klein, H.J., Lowe, R.S., Morton, D.H., Phelps, A.H., McAleer, W.J. and Ellis, R.W. J. Virol. 61:2951–2955, 1987.
Meignier, B. In: The Herpesviruses, Volume 4 (Eds. B. Roizman and C. Lopez), Plenum Press, New York, 1985, pp 265–296.
Hall, M.J. and Katrak, K. Vaccine 4: 138–150, 1986.
Dix, R.D. Prog. Med. Virol. 34:89–128, 1987.
Lopez, C. In: The Herpesviruses, Volume 4, (Eds. B. Roizman and C. Lopez), Plenum Press, New York, 1985, pp 37–68.
Norrild, B. and Teglbjaerg, C.S. In: Herpesvirus, (Ed. F. Rapp), Alan R. Liss, Inc, New York, 1984, pp 23–36.
Rouse, B. T., Norley, S. and Martin, S. Rev. Infect. Dis. 10:16–33, 1988.
Schaller, J.P., Hoover, E.A. and Olsen, R.G. J. Natl. Cancer Inst. 59:1441–1450, 1977.
McGuire, T.C., Adams, D.S., Johnson, G.C., Klevjer-Anderson, P., Barbee, D.D. and Gorham, J.R. Amer. J. Vet. Sci. 47:537–540, 1986.
Martinez-A., C., de la Hera, A., Alonso, I. M., Marcos, M.A.R., Marquez, C., Toribio, M.L. and Coutinho, A. Lancet 1:454–457, 1988.
Robinson Jr., W.E., Montefiori, D.C. and Mitchell, W.M. Lancet 1:830–831, 1988.
Fauci, A. S., Gallo, R.C., Koenig, S., Salk, J. and Purcell, R.H. Ann. Intern. Med. 110:373–385. 1989.
Klatzmann, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T., Gluckman, J. and Montagnier, L. Nature (London) 312:767–768, 1984.
Arthur, L.O., Pyle, S.W., Bess Jr., J.W., Gilden, R.V., Nara, P.L., Robey, W.G., Fischinger, P.J. and Kelliher, J.C. In: Vaccines (Cold Spring Harbor), (Ed. H.M. Ginsberg), Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1988, pp 277–282.
Putney, S.D., Matthews, T.M., Robey, W.G., Lynn, D.L., Robert-Guroff, M., Mueller, W.T., Langlois, A.J., Ghrayeb, J., Petteway Jr., S.R., Weinhold, K.,J., Fischinger, P.J., Wong-Staal, F., Gallo, R.C. and Bolognesi, D.P. Science 234:1392–1395, 1986.
Steimer, K.S., Van Nest, G.A., Haigwood, N.L., Tillson, E.M., George-Nascimento, C., Barr, P.J. and Dina, D. In: Vaccines (Cold Spring Harbor), (Ed. H.M Ginsberg), Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1988, pp 347–355.
Snyder Jr., C.E., Earl, P.L., Todd, W. and Barstad, P.A. In: Technological Advances in Vaccine Development (Ed. L. Lasky), Alan R. Liss, Inc, New York, 1988, pp 311–320.
Gnann Jr., J.W., McCormick, J.B., Mitchell, S., Nelson, J.A. and Oldstone, M.B.A. Science 237:1346–1348, 1987.
Rusche, J.R., Javaherian, K., McDanal, C., Petro, J., Lynn, D.L., Gramaila, R., Langlois, A., Gallo, R.C. and Arthur, L.O. Proc. Natl. Acad. Sci. USA. 85:3198–3202, 1988.
Naylor, P.H., Naylor, C.W., Badamchian, M., Wada, S., Goldstein, A.L., Wang, S.S., Sun, D.K., Thornton, A.H. and Sarin, P.S. Proc. Natl. Acad. Sci. USA, 84:2951–2955, 1987.
Adams, S.E., Senior, J.M., Kingsman, S.M. and Kingsman, A.J. In: Technological Advances in Vaccine Development (Ed. L. Lasky), Alan R. Liss, Inc, New York, 1988, pp 117–126.
Hu, S.L., Fultz, P.N., McClure, H.M., Eichberg, J.W., Thomas, E.K., Zarling, J., Singhai, M.C., Kosowski, S.G., Swenson, R.B., Anderson, D.C. and Todaro, G. Nature 328:721–723, 1987.
Zarling, J.M., Eichberg, J.W., Moran, P.A., McClure, J., Sridhar, P. and Hu, S.L. J. Immunol. 139:988–990. 1987.
Dalgleish, A.G., Thomson, B.J. and Chanh, T.C. Lancet 2:1047–1050, 1987.
Eichberg, J.W. Abstracts of the 5th International Conference on AIDS, Montreal, Quebec, June, 1989, pp 513.
Filici, G., Cereda, P.M. and Varnier, O.E. Nature 335:366–369, 1988.
Kulaga, H., Folks, T., Rutledge, R., Truckenmiller, M.E., Gugel, E. and Kindt, T.J. J. Exp. Med. 169:321–326, 1989.
Letvin, N.L., Daniel, M.D., Sehgal, P.K., Yetz, J.M., Solomon, K.R., Kannagi, M., Schmidt, D.K., Silva, D.P., Montagnier, L. and Desrosiers, R.C. J. Infect. Dis. 156:406–407, 1987.
Daniel, M.D., Letvin, N.L., King, N.W., Kannagi, M., Sehgal, P.K., Hunt, R.D., Kanki, P.J., Essex, M. and Desrosiers, R.C. Science 228:1201–1204, 1985.
Daniel, M.D., Letvin, M.D., Sehgal, P.K., Desrosiers, R.C., Hunt, R.D. Waldron, L.M., MacKey, J.J., Schmidt, D.K., Chalifoux, L.V. and King, N.W. Science 230:71–73, 1985.
Franchini, G., Gurgo, C., Guo, H.G., Gallo, R.C., Collati, E., Fargnoli, K.A., Hall, L.F., Wong-Staal, F. and Reitz, Jr., M.S. Nature 328:539–542, 1987.
Sutjipto, S., Pedersen, N., Gardner, M.B., Hanson, C.V., Miller, C., Gettie, A., Jennings, M., Higgins, J. and Marx, P.A. Abstracts of the 5th International Conference on AIDS, Montreal, Quebec, June, 1989, pp 541.
Pedersen, N.C., Ho, E.M., Brown, M.L. and Yamamoto, J.K. Science 235:790–793. 1987.
Haase, A. T. Nature 322:130–136. 1986.
Cooney, E.L., Zarling, J., Hu, S.L, Watson, A., Corey, L and Greenberg, P. Abstracts of the 5th International Conference on AIDS, Montreal, Quebec, June, 1989, pp 538.
Zagury, D., Picard, O., Bernard, J., Salaun, J.J., Lurhuma, Z. and Gallo, R.C. Abstracts of the 5th International Conference on AIDS, Montreal, Quebec, June, 1989, pp 549.
Dolin, R., Graham, B., Greenberg, S., Tackett, C., Belshe, R., Clements, M., Fernie, B., Stablein, D., Smith, G. and Koff, W. Abstracts of the 5th International Conference on AIDS, Montreal, Quebec, June, 1989, pp 538.
Garrison, L., Midthun, K., dayman, B., Smith, G., Visicidi, R., and the NIAID AIDS Vaccine Evaluation Group. Abstracts of the 5th International Conference on AIDS, Montreal, Quebec, June, 1989, pp 543.
Keefer, M.C., Bonnez, W., Roberts Jr., N.J., Dolin, R. and Reichman, R.C. Abstracts of the 5th International Conference on AIDS, Montreal, Quebec, June, 1989, pp 543.
Goldstein, A.L., Naylor, P.H., Kirkley, J.E., Naylor, C.W., Gibbs, C.J. and Sarin, P.S. Abstracts of the 5th International Conference on AIDS, Montreal, Quebec, June, 1989, pp. 544.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Kluwer Academic Publishers
About this chapter
Cite this chapter
Stanberry, L.R. (1990). Subunit Viral Vaccines: Prophylactic and Therapeutic Use. In: Aurelian, L. (eds) Herpesviruses, the Immune System, and AIDS. Developments in Medical Virology, vol 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1507-0_13
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1507-0_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8810-7
Online ISBN: 978-1-4613-1507-0
eBook Packages: Springer Book Archive